APPA is an aldose reductase inhibitor. APPA can effectively prevent apoptosis and the symptoms of Streptozotocin (HY-13753)-induced diabetes by inhibiting the polyol pathway in rats. APPA has the potential for diabetic nephropathy (DN) research[1].
Molecular Weight:
243.26
CAS Number:
[100750-39-8]
Formula:
C14H13NO3
Target:
Aldose Reductase,Apoptosis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted